Publication

Article

Evidence-Based Oncology

June 2021
Volume27
Issue 4

Weidner et al, Appendices

Author(s):

Susan Weidner, MBA, MS,Michael Diaz, MD

Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology

eAPPENDICES Weidner et al

Download Issue PDF
Articles in this issue
Dollars and Sense
Dollars and Sense
FDA Panel Votes to Keep 4 of 6 “Dangling Approvals,” in a Sign of Things to Come
FDA Panel Votes to Keep 4 of 6 “Dangling Approvals,” in a Sign of Things to Come
Observations Regarding the Average Sales Price Reimbursement Methodology
Observations Regarding the Average Sales Price Reimbursement Methodology
Weidner et al, Appendices
Weidner et al, Appendices
Real-World Evidence Is Key to Accelerating Oncology Approvals
Real-World Evidence Is Key to Accelerating Oncology Approvals
PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?
PATHWAYS: Oncology Care Pathways Launched by Payers: What Are the Trends?
Macmillan
Biosimilars Drive Savings in Medicare’s Oncology Care Model
A Social Worker Leads ACCC, and Her Timing Is Perfect
A Social Worker Leads ACCC, and Her Timing Is Perfect
After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?
After PD-1 Inhibitor Indications Are Withdrawn in SCLC, What Now?
Related Videos
Cathy Eng, MD, FACP, FASCO
Elevating Cancer Care Through Personalized Treatment
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
How Do Infusion Pharmacies Support Financial Sustainability in Oncology?
Screenshot of an interview with Shaun McKenzie, MD
Identifying Good Candidates for Histotripsy to Treat Liver Tumors
Screenshot of an interview with Shaun McKenzie, MD
Histotripsy May Expand Beyond Liver Tumors, but Long-Term Data Are Still Needed
Screenshot of an interview with Rohan Garje, MD
Barriers That Prevent Access to Optimal Treatment in Primary Urethral Cancer
Susan Escudier, MD, FACP
The Need for Payer Support in Overcoming Cancer Care Disparities
Sabarish Ayyappan, MD
Geographic Barriers Impede Access to Novel Cancer Treatments
Fueling Cancer Research Breakthroughs With Patient Contributions
Fueling Cancer Research Breakthroughs With Patient Contributions
Susan Escudier, MD, FACP
Addressing Financial Toxicity and Clinical Trial Disparities in Community Oncology
Screenshot of an interview with Evangelia Vlachou, MD
Enfortumab Vedotin With or Without Pembrolizumab Delivers Promising Responses for Upper Tract Urothelial Cancer
Related Content
FDA Approved. | Image Credit: wladimir1804 - stock.adobe.com
March 26th 2025

FDA Approves Cabozantinib for Advanced Pancreatic Neuroendocrine Tumors

Giuliana Grossi
With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer Network guidelines, this approval reinforces cabozantinib’s role in improving outcomes for patients facing these challenging cancers.
managed care cast logo
October 24th 2024

Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Estrogen | Image credit: Debalina - stock.adobe.com
March 20th 2025

Estrogen Therapy May Increase Risk of 3 Skin Cancers

Hayden E. Klein
Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, but did not recommend discontinuation of any of the drugs studied.
Managed Care Cast logo
April 25th 2024

Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic

Brooke McCormick
On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Texas Oncology logo | Image: Texas Oncology
March 18th 2025

Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot

Mary Caffrey Rose McNulty
Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year
March 17th 2025

Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year

Mary Caffrey
As St. Patrick's Day brings global celebrations involving alcohol, Ireland looks forward to rethinking excess consumption with a new tool set to arrive next year: the world's most comprehensive alcohol warning label.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo